Trv Gp Ii, LLC Jounce Therapeutics, Inc. Transaction History

Trv Gp Ii, LLC

$1.34 Million
Q3 2022

A detailed history of Trv Gp Ii, LLC transactions in Jounce Therapeutics, Inc. stock. As of the latest transaction made, Trv Gp Ii, LLC holds 572,829 shares of JNCE stock, worth $0. This represents 100.0% of its overall portfolio holdings.

Number of Shares

572,829

Previous 1,347,829 57.5%

Holding current value

Previous $4.08 Million 67.19%

% of portfolio

100.0%

Previous 88.46%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$2.73 - $4.92 $2.12 Million - $3.81 Million	-775,000 Reduced 57.5%	572,829 $1.34 Million
Q1 2022 May 10, 2022	SELL	$6.01 - $8.54 $8.11 Million - $11.5 Million	-1,350,000 Reduced 50.04%	1,347,829 $9.15 Million
Q3 2021 Nov 05, 2021	SELL	$5.04 - $8.73 $8.82 Million - $15.3 Million	-1,750,000 Reduced 39.35%	2,697,829 $20 Million
Q2 2021 Aug 11, 2021	SELL	$6.58 - $10.66 $13.5 Million - $21.9 Million	-2,052,520 Reduced 31.58%	4,447,829 $30.2 Million
Q1 2021 May 12, 2021	SELL	$6.73 - $13.87 $18.2 Million - $37.4 Million	-2,700,000 Reduced 29.35%	6,500,349 $66.8 Million
Q4 2020 Feb 16, 2021	SELL	$6.37 - $10.33 $6.56 Million - $10.6 Million	-1,030,000 Reduced 10.07%	9,200,349 $64.4 Million
Q4 2017 Feb 13, 2018	BUY	$12.52 - $17.82 $128 Million - $182 Million	10,230,349	10,230,349 $130 Million

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trv Gp Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trv Gp Ii, LLC with notifications on news.

Account